Glial cells outnumber neurons in the brain and play important roles in the neuroinflammation
that accompanies brain damage in neurodegenerative diseases. In Parkinson’s disease (…

Instead of the progress in the understanding of etiology of Parkinson’s disease (PD), effective
methods to prevent the progression of the disease have not been developed and only …

Introduction: Parkinson disease (PD) is the most common neurodegenerative movement
disorder. Currently only symptomatic treatments exist for PD, and so the search for potential …

… More importantly, this review also emphasizes the potentially new therapeutic targets of … ,
the inflammasome is emerging as a potential therapeutic target. The level of NLRP3 has been …

… targets for PD and even other neurodegenerative diseases. A … and help to establish effective
therapeutic strategies. In this review, … therapeutic interventions targeting neuroinflammation. …

Abnormal aggregation of SNCA/α-synuclein plays a crucial role in Parkinson disease (PD) …
, CMA, represents a viable therapeutic target for PD and other synucleinopathies where …

Parkinson’s disease (PD) is a progressive and chronic neurodegenerative disorder,
characterized by progressive loss of dopaminergic neurons in substantia nigra. The etiology and …

Parkinson disease (PD) is characterized by the progressive loss of nigral dopamine
neurons and the presence of accumulations containing the disease-causing protein SNCA/α-…

Parkinson’s disease (PD) is one of the most common neurodegenerative disorders. The …
We also summarize mitochondria-targeting therapeutics in models of PD, proposing that …

Background: Parkinson's disease is a common disorder that becomes more prevalent with
advanced age. The cardinal features are related to dopamine deficiency, arising from loss of …